EverlyWell, an Austin, TX-based next-generation healthcare testing platform has completed another round of funding led by NextGen Venture Partners with Jack Novak, SoGal Ventures, Full Tilt Capital, including participation from other investors. The latest round brings the company’s total funding to $5 million since its inception in 2015.
EverlyWell offers a suite of regulatory-compliant, physician-reviewed, at-home lab tests, without a lab visit or an in-person doctor referral. The platform currently offers 12 different at-home lab tests including sexual health, thyroid, metabolism, men’s health, and breast milk DHA testing, which the company is the exclusive provider of in the U.S.
EverlyWell works with a physician network to ensure that each at-home lab test is authorized by a board-certified physician in the patient’s state and that their results are reviewed and released by a physician prior to receiving them. A customer selects and purchases a kit that arrives to their home, and he or she collects a sample via pinprick dried blood spot, saliva or urine and sends it to EverlyWell’s certified lab partners.
The lab results are then delivered online via a secure EverlyWell dashboard using infographics and detailed explanations that are easy for patients to share their results with healthcare providers, family and friends. Each lab test also comes with personalized recommendations depending on a customer’s results.
The digital health startup, led by EverlyWell’s CEO and founder, Julia Cheek, reached millions in sales less than a year after its beta launch — while also delivering profitable unit economics. The company now has 15 full-time employees and thousands of customers in 46 states.
“Our vision is to make healthcare services like lab testing accessible, simple, and meaningful for consumers. This additional funding enables us to accelerate our growth even more,” says Julia Cheek, CEO and Founder of EverlyWell in a statement. “We’re leading a major shift in the consumer health marketplace by bringing the lab to consumers’ doorsteps, and we are moving quickly to expand our channels, launch innovative tests, and deliver a world-class customer experience.”
